Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11090311
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11084869
Antibody-mediated neutralization of Marburg virus
granted -
US 11076599
Antimicrobial coating comprising chalcogenide nano-particles capped by chitosan
granted -
US 11078491
Vaccines against Zika virus based on Zika structure proteins
granted -
US 11078256
Methods and compositions for inhibiting cancer cell growth
granted -
US 11065285
Biomarkers and combination therapies using oncolytic virus and immunomodulation
granted -
US 11065223
Antimicrobial compositions and uses thereof
granted -
US 11058766
Universal vaccine platform
granted -
US 11059879
Chimeric antigen receptor molecules and uses thereof
granted -
US 11058802
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11058688
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 11059880
Redirected cells with MHC chimeric receptors and methods of use in immunotherapy
granted -
US 11054423
Antibody-mediated neutralization of ebolaviruses
granted -
US 11045443
Glutaminase inhibitor therapy
granted -
US 11046649
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
granted -
US 11046755
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
granted -
US 11046959
Compositions comprising TALENs and methods of treating HIV
granted -
US 11046670
Piperazinyl norbenzomorphan compounds and methods for using the same
granted -
US 11040959
Diprovocims: a new and potent class of TLR agonists
granted -
US 11033659
Nanofiber structures and methods of synthesis and use thereof
granted -
US 11033612
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
granted -
US 11034739
Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases
granted -
US 11033635
Antibody-STING agonist conjugates and their use in immunotherapy
granted -
US 11033611
Compositions and methods for administration of an enzyme to a subject's airway
granted